-
Miranda Lambert Leads North Texans with Seven Grammy Nominations for 2027
-
DiDi Advances Robotaxi Operations in China with New R2 Vehicle and Expanded Safety Infrastructure
-
Smart Car Seats Tested: Do Sensors and Apps Actually Improve Safety?
-
XPENG Launches Two New Models in UK; Pony.ai Robotaxi Enters Pilot
-
RuffleButts + RuggedButts Featured in Hasbro's 2026 Holiday Gift Guide
-
Dermata Highlights Additional Results and Photos from Cosmetic Study Evaluating Its Tome Foundational Treatment
-
NexCore and MetLife Investment Management Launch $1.3 Billion Senior Living Co-Investment Venture
-
Tectonic Metals Completes Record Drill Program at Flat, Advances Five Pillars of Growth Toward Major 2027 Milestones
-
Glidewell Opens Applications for 2027 Guiding Leaders Cohorts in California and North Carolina
-
International Business Times UK Increases Programmatic Revenue by 30% with Opti Digital
-
Valion Bio Reports Completion of 200-Liter Entolimod Production Run; Material Supplying Ongoing AFRRI Study
-
Miami Allstars FC have Applied to Compete in the Women's Premier Soccer League, with the Club Targeting a 2027 or 2028 Debut in North Miami, Florida
-
Klique Joins Lenovo AI Innovators, Bringing Its Enterprise AI Control Plane to Lenovo Hybrid AI Factory
-
Waste Energy to Host Shareholder Update Today at 4:30 PM EST; Management to Discuss WE #1 Commissioning, Revenue Opportunities and Growth Strategy
-
FaZe Esports, a GameSquare Company, Wins Rainbow Six Championship at Osaka Major
-
Pinnacle Food Group Limited Achieves Laboratory-Scale Astaxanthin Extraction in Haematococcus pluvialis Program
-
BioLargo Reports Third Quarter 2026 Results, Forecasting Commercial Breakout in 2027
-
Viking Global Technologies Announces Expansion of Grid Protection Technology Pilot with Another Major U.S. Electric Utility
-
Nexscient Reports Third Quarter 2026 Results; Revenue Rises Sequentially as Gross Margin Expands to Over 40%
-
TRNR Reports Record Q3 2026 Results, Driven by 66% Revenue Growth; M&A Pipeline Grows Significantly
-
Ur-Energy Commences Baseline Study Fieldwork; Nears Completion of Technical Report at Lost Soldier Uranium Project, Wyoming
-
How to Turn Your Garage into Usable Living Space
-
Pilot-Founded Solara Global Jet Offers Charter, Leases and Air Cargo Nationwide and Overseas
-
Driving Global Innovation - GTDC Summit APJ Underscores Distribution's Transformative Power
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 17
-
PRAAMS AI Co-Investor Now Covers 400,000+ Global Instruments, With Responses From 3 Seconds, Cost From US$0.01, and Scalability to Millions of Users
-
Broad Clinical Labs Drives Strong Digital Engagement by Connecting Customers with Published Research Through Bioz
-
Razavi Law Group Partners with Chapman University to Prepare the Next Generation of Attorneys
-
ImageWorks Display Advances Whole-Store Solutions with a Re-Imagined Planniq Strong and Planniq Chill
-
KIDZ AI Announces Strategic Collaboration with Synestria to Optimize AI Infrastructure Performance
-
Pivotree Announces Third Quarter 2026 Results
-
MedMira Receives U.S. FDA Breakthrough Device Designation for Its Multiplo(R) Complete Syphilis (TP/nTP) Antibody Test
-
Gabriel Resources Provides Corporate and Financing Update
-
HippoFi Achieves OTCID Market Designation, Opening a New Chapter of Commercial Growth
-
Galway Metals Intersects 1.8 g/t Gold Over 25.0 Metres and 0.7 g/t Gold Over 66.0 Metres at Clarence Stream
-
Avino Announces Key Technical Appointment
-
Brightline Interactive and TruWeather Solutions Sign MOU to Bring Weather Data into SpatialCore Physical AI Platform
-
Can Your Trash Can Pass the Holiday 'Eww' Test?
-
RMTG Expands Cellular Hope Institute's Cancún Clinical Facilities and Longevity Platform
-
Platinum Deck and Patio Announces Nashville, Tennessee Launch
-
Wedgewood Weddings Brings Creekside Mountain Celebrations to Idaho Springs with Blackstone Rivers
-
LIBRA Insurance Partners Welcomes Trawick Financial Services to Its Partner Network
-
FibreSeek Expands U.S. Availability of FibreSeeker 3 with Local Stock and Fulfillment
-
DASI Simulations Named to the 2026 CB Insights' 50 Most Promising Digital Health Startups
-
Islo Secures $15 Million Investment Led by Insight Partners to Scale Enterprise Software Factory Platform
-
Bluedrop Medical Appoints Mark Grant as CEO to Advance Commercialization and Strategic Growth
-
Join Nord Precious Metals' Live Investor Webinar: Advancing Silver Production and High-Grade Exploration in Ontario
-
Who Is the Best Plastic Surgeon in the Pacific Northwest?
-
BHG Financial Closes a New ABS Transaction of $495 Million
-
Spider Labs Upgrades YouTube Placement Exclusions in Spider AF
US axes mRNA vaccine contracts, casting safety doubts
President Donald Trump's administration on Tuesday announced it would terminate 22 federal contracts for mRNA-based vaccines, questioning the safety of a technology credited with helping end the Covid pandemic and saving millions of lives.
The announcement, made by Health Secretary Robert F. Kennedy Jr., marks his latest effort to weave vaccine skepticism into the core of US government policy.
"We reviewed the science, listened to the experts, and acted," Kennedy said in a statement.
The health department's Biomedical Advanced Research and Development Authority (BARDA) is "terminating 22 mRNA vaccine development investments because the data show these vaccines fail to protect effectively against upper respiratory infections like COVID and flu," he added.
"We're shifting that funding toward safer, broader vaccine platforms that remain effective even as viruses mutate."
The changes affect Moderna's mRNA bird flu vaccine -- a move the company itself disclosed in May -- as well as numerous other programs, including "rejection or cancellation of multiple pre-award solicitations" from pharmaceutical giants Pfizer and Sanofi.
In total, the affected projects are worth "nearly $500 million," the Department of Health and Human Services (HHS) said. Certain late-stage projects were excluded from the move "to preserve prior taxpayer investment."
"Let me be absolutely clear: HHS supports safe, effective vaccines for every American who wants them," Secretary Kennedy said.
"That's why we're moving beyond the limitations of mRNA and investing in better solutions."
Since taking office, Kennedy, who spent two decades sowing misinformation around immunization, has overseen a major overhaul of US health policy -- firing, for example, a panel of vaccine experts that advise the government and replacing them with his own appointees.
In its first meeting, the new panel promptly voted to ban a longstanding vaccine preservative targeted by the anti-vaccine movement, despite its strong safety record.
He has also ordered a sweeping new study on the long-debunked link between vaccines and autism.
Unlike traditional vaccines, which often use weakened or inactivated forms of the target virus or bacteria, mRNA shots deliver genetic instructions into the host's cells, prompting them to produce a harmless decoy of the pathogen and train the immune system to fight the real thing.
Though in development for decades, mRNA vaccines were propelled from lab benches to widespread use through President Trump's Operation Warp Speed -- a public-private partnership led by BARDA that poured billions into companies to accelerate development.
The technology's pioneers, Katalin Kariko and Drew Weissman, were awarded the 2023 Nobel Prize in Medicine for their work contributing "to the unprecedented rate of vaccine development during one of the greatest threats to human health in modern times."
W.Nelson--AT